Article
Evofosfamide and Gemcitabine Act Synergistically in Pancreatic Cancer Xenografts by Dual…
medRxiv · 2022 · Otowa, Y.; Kishimoto, S.; Saida, Y.; Yamashita, K.; Yamamoto, K.; Chandramouli, G. V.; Devasahayam, N.; Mitchell, J. B.; Krishna, M. C.; Brender, J. R.
Key facts
| Title | Evofosfamide and Gemcitabine Act Synergistically in Pancreatic Cancer Xenografts by Dual Action on Tumor Vasculature and Inhibition of Homologous Recombination DNA Repair |
|---|---|
| First author | Otowa, Y.; Kishimoto, S.; Saida, Y.; Yamashita, K.; Yamamoto, K.; Chandramouli, G. V.; Devasahayam, N.; Mitchell, J. B.; Krishna, M. C.; Brender, J. R. |
| Journal | medRxiv |
| Published | Jul 5, 2022 |
| DOI | 10.1101/2022.07.04.498761 |
| Product codes mentioned | IDO, IDW, IDZ, IEO, KDT, KEQ, KER, KES, KIM, KIO, NNK, PPM and 1 more |
At a glance
- None FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1